Drugs of abuse, sleep, and quality of life

Sleep and Quality of Life in Clinical Medicine

Volumn , Issue , 2008, Pages 341-346

  Johnson, Brian ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Addiction; drug dreams; insomnia; methadone provoked apnea; occult insomnia

Indexed keywords

EID: 77149122343     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-60327-343-5_35     Document Type: Chapter

References (73)

1. Morgan, P.T., et al. Sleep, sleep-dependent procedural learning and vigilance in chronic cocaine users: Evidence for occult insomnia. Drug Alcohol Depend 2006, 82(3): 238-49.
2. Teplin, D., et al. Screening for substance use patterns among patients referred for a variety of sleep complaints. Am J Drug Alcohol Abuse 2006, 32(1): 111-20.
3. D'Mello, D.A., et al. Substance dependence and the use of pro re nata anxiolytic/hypnotic drugs in a hospital setting. Addict Behav 2000, 25(3): 441-3.
4. Wong, M.M., et al. Sleep problems in early childhood and early onset of alcohol and other drug use in adolescence. Alcohol Clin Exp Res 2004, 28(4): 578-87.
5. Volkow, N.D., Fowler, J.S., and Wang, G-J. The addicted human brain viewed in the light of imaging studies: Brain circuits and treatment strategies. Neuropharmacology 2004. 47:3-13.
6. Robinson, T.E. and K.C. Berridge. The neural basis of drug craving: An incentive-sensitization theory of addiction. Brain Res Rev 1993, 18: 247-91.
7. Panksepp, J. Affective Neuroscience. New York: Oxford University Press, 1998
8. Nestler, E.J. Is there a common molecular pathway for addiction? Nature Neurosci 2005, 8: 1445-9.
9. Solms, M. Dreaming and REM sleep are controlled by different mechanisms. Behav Brain Sci 2000, 23: 843-50.
10. McGregor, C., et al. The nature, time course and severity of methamphetamine withdrawal. Addiction 2005, 100(9): 1320-9.
11. Valladares, E.M., S.M. Lee, T.F. Newton, T. Fong, C.L. Ehlers, and M.R. Irwin. Sleep dysregulation in cocaine dependent men during acute abstinence. Sleep 2006, 29: Abstract Suppl. A334.
12. Oyefeso, A., P. Sedgwick, and H. Ghodse. Subjective sleep-wake parameters in treatment-seeking opiate addicts. Drug Alcohol Depend 1997, 48(1): 9-16.
13. Stein, M.D., et al. Sleep disturbances among methadone maintained patients. J Subst Abuse Treat 2004, 26(3): 175-80.
14. Freye, E. and J. Levy. Acute abstinence syndrome following abrupt cessation of long-Term use of tramadol (Ultram): A case study. Eur J Pain 2000, 4(3): 307-11.
15. Beswick, T., et al. Major disruptions of sleep during treatment of the opiate withdrawal syndrome: Differences between methadone and lofexidine detoxification treatments. Addict Biol 2003, 8(1): 49-57.
16. Stein, M.D., D.S. Herman, S. Bishop, J.A. Lassor, M. Weinstock, J. Anthony, and B.J. Anderson. Sleep disturbances among methadone maintained patients. J Subst Abuse Treat 2004, 26: 175-80.
17. Peles, E., S. Schreiber, and M. Adelson. Variables associated with perceived sleep disorders in methadone maintenance treatment (MMT) patients. Drug Alcohol Depend, 2006, 82(2): 103-10.
18. Staedt, J., et al. Effects of chronic treatment with methadone and naltrexone on sleep in addicts. Eur Arch Psychiatry Clin Neurosci, 1996, 246(6): 305-9.
19. Bovasso, G. and J. Cacciola, The long-Term outcomes of drug use by methadone maintenance patients. J Behav Health Serv Res, 2003, 30(3): 290-303.
20. Durst, P., et al. Methadone and sleep apnea syndrome. Can J Psychiatry, 2005, 50(3): 153-8.
21. Wang, D., et al. Central sleep apnea in stable methadone maintenance treatment patients. Chest, 2005, 128(3): 1348-56.
22. Srivastava, A., and M. Kahan. Methadone induction doses: Are our current practices safe? J Addict Dis 2006. 25(3): 5-13.
23. Vandrey, R.G., et al. A cross-study comparison of cannabis and tobacco withdrawal. Am J Addict 2005, 14(1): 54-63.
24. Haney, M. The marijuana withdrawal syndrome: diagnosis and treatment. Curr Psychiatry Rep 2005, 7(5): 360-6.
25. Baylen, C.A. and H. Rosenberg. A review of the acute subjective effects of MDMA/ecstasy. Addiction 2006, 101(7): 933-47.
26. Huxster, J.K., A. Pirona, and M.J. Morgan. The sub-Acute effects of recreational ecstasy (MDMA) use: a controlled study in humans. J Psychopharmacol 2006. 20(2): 281-90.
27. Parrott, A.C. MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress. J Psychopharmacol 2006, 20(2): 147-63.
28. Roehrs, T., M. Tancer, and C. Johanson. Sleep and daytime alertness in drug free mdma users. Sleep 2006, 29: Abstract Suppl. A42.
29. Klein-Schwartz,W. Abuse and toxicity of methylphenidate. Curr Opin Pediatr 2002, 14(2): 219-23.
30. Galloway, G.P., et al. Gamma-hydroxybutyrate: an emerging drug of abuse that causes physical dependence. Addiction 1997, 92(1): 89-96.
31. Gee, P., et al. Toxic effects of BZP-based herbal party pills in humans: a prospective study in Christchurch, New Zealand. N Z Med J 2005, 118(1227): U1784.
32. Johnson, B. The mechanism of codependence in the prescription of benzodiazepines to patients with addiction. Psychiatric Annals 1998, 28: 166-71.
33. Ghaemi, N.S. Hippocratic psychopharmacology. Psychiatry. 2006, 3: 30-9.
34. Longo, L.P. and B. Johnson. Treatment of insomnia in substance abusing patients. Psychiatric Annals 1998, 28: 154-9.
35. Janssen, P.A., L.C. Demorest, and E.M. Whynot. Acupuncture for substance abuse treatment in the Downtown Eastside of Vancouver. J Urban Health 2005, 82(2): 285-95.
36. Longo, L.P. Non-benzodiazepine pharmacotherapy of anxiety and panic in substance abusing patients. Psychiatric Annals 1998, 28: 142-53.
37. Chapman, J.B., et al. Sleep quality and the role of sleep medications for veterans with chronic pain. Pain Med 2006. 7(2): 105-14.
38. Pinkofsky, H.B., et al. Reduction of opioid-withdrawal symptoms with quetiapine. J Clin Psychiatry 2005, 66(10): 1285-8.
39. Sattar, S.P., S.C. Bhatia, and F. Petty. Potential benefits of quetiapine in the treatment of substance dependence disorders. J Psychiatry Neurosci 2004, 29(6): 452-7.
40. Salloum, I.M., et al. Divalproex utility in bipolar disorder with co-occurring cocaine dependence: A pilot study. Addict Behav 2007, 32: 410-15.
41. Liappas, I.A., et al. Zolpidem dependence case series: possible neurobiological mechanisms and clinical management. J Psychopharmacol 2003, 17(1): 131-5.
42. Johnson, B. Commentary on Simon Boag's "Freudian dream theory, dream bizarreness and the disguise-censor controversy. Neuro-Psychoanalysis 2006, 8: 33-40.
43. Petersen, T., et al. A survey of prescribing practices in the treatment of depression. Prog Neuropsychopharmacol Biol Psychiatry 2002, 26(1): 177-87.
44. Johnson, B. Drug dreams: a neuropsychoanalytic hypothesis. J Am Psychoanal Assoc 2001, 49: 75-96.
45. Scott, E.M. Dreams of alcoholics. Percept Mot Skills 1968, 26: 1315-8.
46. Choi, S.M. Dreams as a prognostic factor in alcoholism. Am J Psychiatry 1973, 130: 699-702.
47. Fiss, H. Dream content and response to withdrawal from alcohol. Sleep Res 1980, 9: 152.
48. Denizen, N.K. Alcoholic dreams. Alcohol Treat Q 1988, 5: 133-9.
49. Johnson, B. Psychological addiction, physical addiction, addictive character, addictive personality disorder: a new nosology of addiction. Can J Psychoanal 2003, 11: 135-60.
50. Hajek, P. and M. Belcher. Dream of absent-minded transgression: an empirical study of a cognitive withdrawal symptom. J Abnorm Psychol 1991, 100: 487-91.
51. Persico, A.M. Predictors of smoking cessation in a sample of Italian smokers. Int J Addict 1992, 27: 683-95.
52. Jerry, P.A. Psychodynamic psychotherapy of the intravenous cocaine abuser. J Subst Abuse Treat 1997, 14: 319-32.
53. Flowers, L.K. and J.E. Zweben. The changing role of "using" dreams in addiction recovery. J Subst Abuse Treat 1998, 15: 193-200.
54. Reid, S.D. and D.T. Simeon. Progression of dream of crack cocaine as a predictor of treatment outcome: a preliminary report. J Nerv Ment Dis 2001, 189: 854-7.
55. Yee, T., D.C. Perantie, N. Dhanani, and E.S. Brown. Drug dreams in outpatients with bipolar disorder and cocaine dependence. J Nerv Ment Dis 2004, 192: 238-42.
56. Looney, M. The dreams of heroin addicts. Soc Work 1972, 17: 23-8.
57. Colace, C. Dreams in abstinent opiate drug addicts: a case reports study. Sleep 1999, 22 (Suppl. 1): 175-6.
58. Colace, C. Dreams in abstinent heroin addicts: Four case reports. Sleep Hypn 2000, 2: 160-3.
59. Colace, C. Dreaming in addiction, a study on the motivational bases of dreaming process. Neuropsychoanalysis 2004, 6:165-79.
60. Jones, D.S., Krotick, S., Johnson, B., and Morrison, A.P.Waiting for rescue: An attorney who will not advocate for himself. Harv Rev Psychiatry 2005, 13: 244-56.
61. Christo, G. and C. Franey. Addicts' drug-related dreams: their frequency and relationship to six-month outcomes. Subst Use Misuse 1996, 31: 1-15.
62. Araujo, R.B., M. Oliveira, and L.B. Piccoloto. Dreams and craving in alcohol addicted patients in the detoxification stage. Rev Psychiatr Clin 2004, 31: 63-9.
63. Yu, C.K. Neuroanatomical correlates of dreaming II: The ventromesial frontal region controversy (dream instigation). Neuropsychoanalysis 2001, 3: 193-201.
64. Hobson, J.A. The Dreaming Brain. New York: Basic Books, 1988.
65. Hobson, J.A. The new neuropsychology of sleep. Neuropsychoanalysis 1999, 1: 157-83.
66. Hobson, J.A. The Dream Drugstore Cambridge. Cambridge, MA: MIT Press, 2001.
67. Hobson, J.A. and E.F. Pace-Schott. Responses to commentaries. Neuropsychoanalysis 1999, 1: 206-24.
68. Hobson, J.A., E.F. Pace-Schott, and R. Stickgold. Dreaming and the brain: Toward a cognitive neuroscience of conscious states. Behav Brain Sci 2000, 23: 793-842.
69. Reiser, M.F. The new neuropsychology of sleep commentary. Neuropsychoanalysis 1999, 1: 201-6.
70. Hartmann, E. The waking-To-dreaming continuum and the effects of emotion. Behav Brain Sci 2000, 23: 947-50.
71. Greenberg, R. Where is the forest? Where is the dream? Behav Brain Sci 2000, 23: 943-5.
72. Johnson, B., Review of J. Alan Hobson, The Dream Drugstore. Nature 2002, 415: 368-9.
73. Johnson, B. Review of J. Alan Hobson, The Dream Drugstore, Neuropsychoanalysis 2002, 4: 119-21.